Babraham announces new bioincubator building programme for 2010


Babraham Bioscience Technologies Ltd (BBT) today announced the initiation of a new bioincubator building programme at the Babraham Research Campus, further expanding Babraham’s capacity for supporting early-stage companies and biomedical innovation.

SDC Builders Ltd have been appointed as the main contractor for the construction of the new Bioincubator facility at the Babraham Research Campus. The new 8800 sq ft facility is designed to provide accommodation for up to 16 early stage biomedical companies at the heart of the Cambridge Biomedical cluster. 

The building has been designed to allow maximum flexibility in use so that combinations of office, laboratory, cell culture and containment level 2 facilities can readily be provided according to the specific needs of early stage companies.  

The building will also provide communal laboratory equipment and meeting areas. Building work will commence in January 2010, and it is expected that the new Bioincubator space will be available to tenants in September 2010. 


Babraham Bioscience Technologies Ltd is the wholly-owned subsidiary and trading arm of the Babraham Institute. Coalescing scientific, technological and commercial excellence, BBT delivers the Knowledge Transfer remit of the Institute through the wider landscape of the Babraham Research Campus, catalysing opportunities for enterprise across the academic and commercial divide. BBT brings together all the elements to support innovation and enable the successful exploitation of research in the biomedical sector based on technologies emanating from the Babraham Institute and bioventures relocating to the Babraham Research Campus. Website:
The Babraham Research Campus is the UK’s leading knowledge-driven Biomedical Park where world-class research, business know-how and entrepreneurial excellence come together to stimulate effective knowledge transfer and bridge the academic and commercial divide. The campus provides a unique and highly successful environment that actively fosters innovation and plays a pivotal role for biomedical start-up companies in the Cambridge region and with delivering innovation at the frontiers of biomedical research. BBT has taken a prominent role regionally, initiating and leading partnerships to promote knowledge and skills flow and has established a reputation for successfully translating innovative science into viable business opportunities through partnerships for wealth creation. This is stimulating inward investment to the campus and contributing to regional development.

The Babraham Institute, an independent charitable organisation located six miles south-east of Cambridge, is an institute of the Biotechnology and Biological Sciences Research Council. Carrying out world-leading innovative research and advanced training with relevance to the biomedical, biotechnological, pharmaceutical and healthcare communities, the institute underpins government’s national responsibilities for healthcare research and training. Research focuses on the mechanisms of cell signalling and gene regulation, which underlie normal cellular processes and functions, and on how their failure or abnormality may lead to disease. The latest technologies are being used to study the basis of conditions such as neurodegenerative disorders, foetal abnormality, cancer and diseases of the immune and cardiovascular systems. The commercialisation of the Institute’s research is managed by its trading subsidiary, Babraham Bioscience Technologies Ltd. Website:
Contact details:
Derek Jones,
Chief Executive Officer
Babraham Bioscience Technologies Ltd
Babraham Research Campus
Cambridge CB22 3AT
United Kingdom
Tel: +44 (0)1223 496262
Dr Claire Cockcroft,
Head, External Relations
The Babraham Institute
Tel: +44 (0)1223 496260
Fax: +44 (0)1223 496002


The Institute is an independent charitable life sciences research institute, strategically funded by the Biotechnology and Biological Sciences Research Council.

Babraham Institute